StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals U.S. federal statutory income tax rate by Year

U.S. federal statutory income tax rate (%) (%)

Vertex Pharmaceuticals U.S. federal statutory income tax rate: 2,100.0% in FY2025, unchanged from a year earlier. That is the lowest of the 9 years on record here.

Latest, FY2025
2,100.0%
Period ended Dec 31, 2025
Change on a year earlier
0.0 pts
2,100.0% in FY2024
History
9 years
Since FY2015
Sources
6
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-K Note (Income Taxes).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. federal statutory income tax rate (%) (%)Year on yearSource
FY2025Dec 31, 20252,100.0%0.0 ptsForm 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 20242,100.0%0.0 ptsForm 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 20232,100.0%0.0 ptsForm 10-K (filed 2026-02-13) ↗
FY2022Dec 31, 20222,100.0%0.0 ptsForm 10-K (filed 2025-02-13) ↗
FY2021Dec 31, 20212,100.0%0.0 ptsForm 10-K (filed 2024-02-15) ↗
FY2020Dec 31, 20202,100.0%0.0 ptsForm 10-K (filed 2023-02-10) ↗
FY2019Dec 31, 20192,100.0%–Form 10-K (filed 2022-02-09) ↗
FY2016Dec 31, 20163,500.0%0.0 ptsForm 10-K (filed 2017-02-23) ↗
FY2015Dec 31, 20153,500.0%–Form 10-K (filed 2017-02-23) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals U.S. federal statutory income tax rate (%), annual FY2015–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/stat-tax-rate

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.